| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 58 companies in the Health Care Technology industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 30, 2023 | GDRX Goodrx Holdings, Inc. | Wagner Scott | See Remarks | Buy | 21,652 | $5.76 | $124,806.46 | +13.4% | +8.0% | -19.2% | |
| Nov 30, 2023 | SPOK Spok Holdings, Inc | Rice Calvin76 | Chief Financial Officer &CAO | Sell | 13,000 | $16.91 | $219,830.00 | -64.9% | +5.1% | -2.1% | |
| Nov 29, 2023 | GDRX Goodrx Holdings, Inc. | Wagner Scott | See Remarks | Buy | 30,505 | $5.91 | $180,422.52 | +11.5% | +13.6% | -16.6% | |
| Nov 29, 2023 | TBRG Trubridge, Inc. | Fowler Christopher L76 | President And CEO | Buy | 16 | $11.16 | $178.63 | +69.6% | -13.4% | +65.6% | |
| Nov 27, 2023 | SPOK Spok Holdings, Inc | Stein Todd J91 | Director | Sell | 51,103 | $17.95 | $917,160.87 | -2.8% | -2.5% | -8.5% | |
| Nov 27, 2023 | TDOC Teladoc Health, Inc. | Geshuri Arnnon84 | Chief People Officer | Sell | 346 | $17.04 | $5,895.84 | -1.2% | -14.1% | -33.9% | |
| Nov 24, 2023 | DOCS Doximity, Inc. | Wampler Kira Scherer53 | Director | Sell | 2,500 | $24.41 | $61,025.00 | -19.6% | +18.1% | +96.3% | |
| Nov 24, 2023 | TXG 10x Genomics, Inc. | Saxonov Serge80 | Chief Executive Officer | Sell | 7,480 | $43.52 | $325,566.93 | -0.4% | +5.1% | -67.0% | |
| Nov 22, 2023 | TXG 10x Genomics, Inc. | Wilbur James69 | Chief Commercial Officer | Sell | 3,464 | $43.34 | $150,118.33 | -4.0% | +9.5% | -69.3% | |
| Nov 22, 2023 | TXG 10x Genomics, Inc. | Hindson Benjamin J.82 | See Remarks | Sell | 3,449 | $43.34 | $149,468.28 | -1.2% | +9.5% | -69.3% | |
| Nov 22, 2023 | TXG 10x Genomics, Inc. | McAnear Justin J.84 | Chief Financial Officer | Sell | 1,679 | $43.34 | $72,762.32 | -1.7% | +9.5% | -69.3% | |
| Nov 22, 2023 | NRC National Research Corp | Amandla Mk Trust69 | 10% Owner | Sell | 784 | $42.07 | $32,986.73 | - | -6.4% | -53.4% | |
| Nov 20, 2023 | TXG 10x Genomics, Inc. | Wilbur James69 | Chief Commercial Officer | Sell | 14,718 | $42.09 | $619,493.87 | -14.5% | +9.3% | -68.7% | |
| Nov 17, 2023 | TDOC Teladoc Health, Inc. | Trencher Daniel85 | Chief Strategy Officer | Sell | 1,000 | $17.07 | $17,070.00 | -5.0% | +25.9% | -46.4% | |
| Nov 17, 2023 | GDRX Goodrx Holdings, Inc. | Wagner Scott | See Remarks | Buy | 130,743 | $5.18 | $677,475.06 | +125.6% | +28.7% | -20.7% | |
| Nov 16, 2023 | DOCS Doximity, Inc. | Overpeck Craig | See Remarks | Sell | 1,500 | $25.23 | $37,845.00 | -1.3% | +15.7% | +94.5% | |
| Nov 15, 2023 | NRC National Research Corp | Amandla Mk Trust69 | 10% Owner | Sell | 403 | $42.10 | $16,967.79 | - | -8.8% | -53.9% | |
| Nov 15, 2023 | HCAT Health Catalyst, Inc. | Llewelyn Linda82 | Chief People Officer | Sell | 1,196 | $8.25 | $9,867.00 | -1.5% | +19.7% | +5.4% | |
| Nov 15, 2023 | EVH Evolent Health, Inc. | McCarthy Daniel Joseph66 | President | Sell | 11,000 | $30.00 | $330,000.00 | -1.8% | +2.3% | -57.3% | |
| Nov 14, 2023 | TXG 10x Genomics, Inc. | Saxonov Serge80 | Chief Executive Officer | Sell | 2,000 | $39.52 | $79,040.60 | -0.2% | +23.2% | -62.6% | |
| Nov 9, 2023 | CCLD Carecloud, Inc. | Busquet Anne | Director | Buy | 83,038 | $1.17 | $97,177.02 | +25.3% | -4.1% | +120.5% | |
| Nov 8, 2023 | SLP Simulations Plus, Inc. | Paglia John Kenneth61 | Director | Sell | 1,000 | $35.25 | $35,250.00 | -24.4% | +8.5% | -12.7% | |
| Nov 6, 2023 | VEEV Veeva Systems Inc | Wallach Matthew J58 | Director | Sell | 5,000 | $195.53 | $977,641.38 | -1.0% | +4.1% | +8.4% | |
| Nov 6, 2023 | SPOK Spok Holdings, Inc | Byrne Barbara Peterson61 | Director | Buy | 10,000 | $15.96 | $159,627.00 | +43.0% | +6.7% | +1.9% | |
| Nov 6, 2023 | VEEV Veeva Systems Inc | Mateo Alan66 | EVP Global Sales | Sell | 6,280 | $193.72 | $1,216,592.02 | -12.6% | +4.1% | +8.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.